Sign in

CIK 0001023024

  • Large accelerated filer

ANI PHARMACEUTICALS INC

Sign in to watch
Ticker
ANIP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
582301143
Phone
+1 609-759-1810
Business address
104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
Former names
BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$2,359,736
in 11 filings, $2.4M under 10b5-1 plans

Net −$2,359,736. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-03-15 RAYNOR DANIEL Director Sale −1,902 $61.50 $117K 294,316
2018-03-14 MARSHBANKS TRACY Director Sale −1,912 $63.10 $121K 483,801
2018-03-14 PRZYBYL ARTHUR President and CEO Sale −10,000 $62.03 $620K 185,706
2018-03-14 RAYNOR DANIEL Director Sale −1,919 $62.02 $119K 296,218
2018-03-13 PRZYBYL ARTHUR President and CEO Sale −23,475 $61.52 $1.4M 202,231
2018-03-13 PRZYBYL ARTHUR President and CEO Sale −6,525 $62.63 $409K 195,706
2018-03-13 RAYNOR DANIEL Director Sale −14,000 $61.81 $865K 302,254
2018-03-13 RAYNOR DANIEL Director Sale −4,117 $62.59 $258K 298,137
2018-03-12 PRZYBYL ARTHUR President and CEO Exercise or conversion +15,723 $6.36 $100K 225,706
2018-03-12 PRZYBYL ARTHUR President and CEO Exercise or conversion · Stock Option −15,723 0
2018-03-12 RAYNOR DANIEL Director Sale −7,928 $62.88 $499K 316,254
2018-03-12 MARSHBANKS TRACY Director Sale −12,269 $63.03 $773K 485,713
2018-03-09 MARSHBANKS TRACY Director Sale −36,561 $63.01 $2.3M 497,982
2018-03-08 MARSHBANKS TRACY Director Sale −15,391 $63.08 $971K 534,543
2018-03-05 Marken James G. SVP Ops & Prod Dev Exercise or conversion +14,793 $6.36 $94K 66,439
2018-03-05 Marken James G. SVP Ops & Prod Dev Exercise or conversion +3,208 $33.00 $106K 69,647
2018-03-05 Marken James G. SVP Ops & Prod Dev Sale −4,177 $61.92 $259K 65,470
2018-03-05 Marken James G. SVP Ops & Prod Dev Exercise or conversion · Stock Options −14,793 0
2018-03-05 Marken James G. SVP Ops & Prod Dev Exercise or conversion · Stock Options −3,208 1,667
2018-03-01 Schrepfer Robert W SVP - New Bus Dev & Spec Sales Exercise or conversion +18,750 $28.76 $539K 41,590

Page 33 of 41 · 804 trades